The S&P/ASX 200 Health Care Index fell 1.85% in December but rose ... December after failure of phase 2b trial of avicursen ...
Stockhead on MSN12d
ASX December Winners: Santa didn’t rally but at least these 50 stocks went okayAustralia's S&P/ASX 200 dropped 3.15% in December to 8.159.1, the worst monthly return of 2024. The fall effectively erased ...
“Current cash backing likely sits around $20 million but considering cash burn and trial close-out costs we see Percheron sitting with around $10 million (equivalent to 1 cent/share) in 12 months time ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback